Inkcazo
I-tofacitinib yethu ephakathi ibaluleke kakhulu kwinkqubo yokwenziwa kwe-tofacitinib, ichiza elaziwayo elisetyenziselwa ukunyanga iintlobo ezithile ze-arthritis.Esi siphakathi sidlala indima ebalulekileyo kwimveliso ye-tofacitinib, igalelo ekusebenzeni kwayo kunye nomgangatho.Nge (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy]succinic acid kunye (3R,4R)-N,4-dimethyl-1- (phenylmethyl)- Inhlanganisela echanekileyo ye-3-piperidinamines, yethu imveliso iqinisekisa ukuhlanganiswa komgangatho ophezulu we-tofacitinib odibana kunye nokugqithisa imigangatho yoshishino.
Ifomula yemolekyuli kunye nobunzima be-tofacitinib yethu ephakathi ibonisa ubunyulu kunye namandla, oko kuyenza ibe yinxalenye ethembekileyo yenkqubo yokuvelisa amayeza.Ngezithako zayo ezilinganiswe ngononophelo, le ndawo iphakathi iqinisekisa ukuhambelana kunye nokusebenza kwemveliso yokugqibela, i-tofacitinib.Iipropathi zayo zeemolekyuli zikwanegalelo kuzinzo jikelele lwe-tofacitinib kunye nobomi beshelufa, ukuqinisekisa ukuba ihlala isebenza kwaye ithembekile kwixesha elide.
Khetha Thina
I-JDK iphethe izixhobo zokuvelisa iklasi yokuqala kunye nezixhobo zokulawula uMgangatho, oqinisekisa ukunikezelwa okuzinzile kwe-API intermediates.Iqela lobuchwephesha liqinisekisa iR&D ngemveliso.Ngokuchasene nazo zombini, sikhangela i-CMO kunye ne-CDMO kwimarike yasekhaya neyamanye amazwe.